Lumida
/HWKN
⌘K
Hawkins Inc

Hawkins Inc

HWKN
$144.41USD+0.94%+1.35 today

MARKET CAP

3.0B

P/E (TTM)

36.9x

FWD P/E

32.4x

DAY RANGE

$140 – $148

52W RANGE

$118
$186

AI Summary

Stalk
Buy NowMedium

Stage 2 corrective reset shows uptrend resuming, supported by a Lockout Rally pattern driving urgency-based repricing. Price has pulled back into an oversold confluence of the repaired 9/21 EMAs near the mid-June swing low. Medium-term bias remains bullish within the broader advance, though overhead 50/200 DMA resistance poses a transition risk. Short-term conditions are favorable for immediate entry on pullback absorption, targeting the repaired EMA support zone.

  • Average MarketBeat target $185 implies 38% upside from $133.76.
  • High earnings yield indicates robust return relative to peers.
  • P/E of 34.2 versus 19.8 historical median suggests overvaluation.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Hawkins Inc. (HWKN) is a leading player in the chemical and materials industry, specializing in the manufacturing and distribution of various specialty chemicals. The company serves multiple sectors, including food and beverage, pharmaceuticals, and industrial applications, positioning it strategically within the growing demand for specialty materials across diverse industries. With a strong emphasis on quality and safety, Hawkins has established a reputation for reliability and innovation.

Bull says

  • Average MarketBeat target $185 implies 38% upside from $133.76.
  • High earnings yield indicates robust return relative to peers.
  • Strong margin conversion shows efficient revenue-to-profit operations.
  • Low leverage underpins a clean, resilient balance sheet.
  • Positive analyst earnings revisions point to rising EPS forecasts.
  • Consensus Buy with avg $193 target underscores market confidence.

Bear says

  • P/E of 34.2 versus 19.8 historical median suggests overvaluation.
  • Intrinsic‐value analysis flags ~1.7% overvaluation on book‐to‐price basis.
  • Negative short‐term momentum warns of potential price weakness.
  • Declining 13F holdings reflect waning institutional conviction.
  • Dividend yield 0.57% lags peers, limiting shareholder returns.
  • Market skepticism over priced‐in growth may cap further gains.